Rothfuss Cristin 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 3, 2026
Insider Transaction Report
Form 4
Rothfuss Cristin
EVP, General Counsel
Transactions
- Tax Payment
Common Stock
[F1]2026-03-02$16.20/sh−408$6,610→ 139,348 total
Footnotes (1)
- [F1]Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024.
Signature
/s/ Cristin L. Rothfuss|2026-03-03